Different skin thinning potential of equipotent medium-strength glucocorticoids
- PMID: 11867964
- DOI: 10.1159/000049394
Different skin thinning potential of equipotent medium-strength glucocorticoids
Abstract
In this study, we investigated the effect of prednicarbate, mometasone furoate and betamethasone 17-valerate on total skin thickness over a treatment period of 6 weeks. The study was conducted as a double-blind, placebo-controlled randomized clinical trial with a confirmatory approach. The influence of these drugs on healthy human skin under non-occlusive conditions was assessed by measuring total skin thickness and epidermal thickness using 20 and 50 MHz sonography, respectively. Epidermal surface structure was evaluated using profilometry. Visual assessment addressed signs of atrophy and formation of telangiectasia. The reduction of total skin thickness induced by prednicarbate was clearly less than that caused by betamethasone 17-valerate and mometasone furoate. Prednicarbate led to a higher degree of skin thinning than vehicle. For technical reasons, epidermal thickness could not be reliably evaluated with 50 MHz sonography. Profilometry did not demonstrate any differences between treatments. Visible signs of atrophy or telangiectasia were detected in two subjects each upon betamethasone 17-valerate and mometasone furoate, but not upon prednicarbate or its vehicle. Prednicarbate is a topical glucocorticoid with an improved benefit/risk ratio, as it causes less skin atrophy than the equipotent betamethasone 17-valerate.
Copyright 2002 S. Karger AG, Basel
Similar articles
-
0.25% prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17-propionate cream.Eur J Clin Pharmacol. 1992;42(2):159-61. doi: 10.1007/BF00278477. Eur J Clin Pharmacol. 1992. PMID: 1618247 Clinical Trial.
-
Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoids.Clin Pharmacol Ther. 1993 Oct;54(4):448-56. doi: 10.1038/clpt.1993.172. Clin Pharmacol Ther. 1993. PMID: 8222488 Clinical Trial.
-
In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid as compared to other topical glucocorticoids old and new.Int J Clin Pharmacol Ther. 1995 Apr;33(4):187-9. Int J Clin Pharmacol Ther. 1995. PMID: 7620686 Clinical Trial.
-
Topical glucocorticoids with improved benefit/risk ratio: do they exist?J Am Acad Dermatol. 1992 Jul;27(1):87-92. doi: 10.1016/0190-9622(92)70162-9. J Am Acad Dermatol. 1992. PMID: 1619082 Review.
-
Topical mometasone. A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders.Drugs. 1998 Jan;55(1):145-63. doi: 10.2165/00003495-199855010-00009. Drugs. 1998. PMID: 9463794 Review.
Cited by
-
11β-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects.J Clin Invest. 2013 Jul;123(7):3051-60. doi: 10.1172/JCI64162. Epub 2013 Jun 3. J Clin Invest. 2013. PMID: 23722901 Free PMC article.
-
Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial.Eur J Endocrinol. 2022 Feb 28;186(4):441-455. doi: 10.1530/EJE-21-1197. Eur J Endocrinol. 2022. PMID: 35113805 Free PMC article. Clinical Trial.
-
Test systems for the determination of glucocorticoid receptor ligand induced skin atrophy.Dermatoendocrinol. 2011 Jul;3(3):175-9. doi: 10.4161/derm.3.3.15065. Epub 2011 Jul 1. Dermatoendocrinol. 2011. PMID: 22110776 Free PMC article.
-
Efficacy and Safety of Crisaborole Ointment, 2%, for the Treatment of Mild-to-Moderate Atopic Dermatitis Across Racial and Ethnic Groups.Am J Clin Dermatol. 2019 Oct;20(5):711-723. doi: 10.1007/s40257-019-00450-w. Am J Clin Dermatol. 2019. PMID: 31264114 Free PMC article. Clinical Trial.
-
Comparative safety and efficacy of topical mometasone furoate with other topical corticosteroids.Australas J Dermatol. 2018 Aug;59(3):e168-e174. doi: 10.1111/ajd.12762. Epub 2018 Feb 7. Australas J Dermatol. 2018. PMID: 29411351 Free PMC article. Review.